Yes Bank: The top loser of the year Yes Bank: The top loser of the year Gayathri Udyawar / Tuesday, August 13, 2019 / Article rating: 3.9 With the benchmark indices witnessing another session of heavy sell-off, Yes Bank was the biggest loser on Tuesday. Shares of Yes Bank hit a fresh 52-week low of Rs. 72.85 and closed at Rs. 73.60 per share, down by 10.35 per cent on BSE.
Personal finance tips of all time Personal finance tips of all time Henil Shah / Tuesday, August 13, 2019 / Article rating: 3.3 It is really important to focus on personal finance and not just on financial planning. Here are some personal finance tips of all time.
Gayatri Projects wins Rs. 914 crore arbitration claims Gayatri Projects wins Rs. 914 crore arbitration claims Amir Shaikh / Tuesday, August 13, 2019 / Article rating: 3.7 Gayatri Projects (GPL) in its exchange filing said that the company along with its joint venture partner IL&FS Engineering & Construction has won an arbitration claim of worth Rs. 914.3 crore for the Nagaland project.
Torrent Pharma receives OAI from USFDA Torrent Pharma receives OAI from USFDA Amir Shaikh / Tuesday, August 13, 2019 / Article rating: 3.5 Torrent Pharma has received a communication from the USFDA classifying the inspection conducted at its Indrad facility as official action initiated (OAI), on Monday.
Pidilite Industries to foray into tile and flooring products Pidilite Industries to foray into tile and flooring products Pratik Shastri / Tuesday, August 13, 2019 / Article rating: 5.0 Leading adhesive manufacturer Pidilite Industries entered joint ventures with Spanish and Italian firms for a range of products and utilities.
Ten stocks close to their 52-weeks high Ten stocks close to their 52-weeks high Shital Jibhe / Tuesday, August 13, 2019 / Article rating: 5.0 The markets on August 13, 2019 opened gap down. BSE Sensex is trading at 37,386.31, down by 195.60 points and the Nifty is trading at 11,058.35, down by 51.30 points.
Alembic Pharma dips by 2 per cent despite USFDA approvals Alembic Pharma dips by 2 per cent despite USFDA approvals Geyatee Deshpande / Tuesday, August 13, 2019 / Article rating: 5.0 Alembic Pharma has received two approvals from the US Food & Drug Administration (USFDA) for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2% and also for Fenofibrate Tablets USP, 48 mg and 145 mg. Despite this development, the stock of the company was down by 2.22 per cent.
Dilip Buildcon wins project worth Rs. 972 crore Dilip Buildcon wins project worth Rs. 972 crore Shohini Nath / Tuesday, August 13, 2019 / Article rating: 3.6 Shares of Dilip Buildcon soared high as over 2 per cent intraday on Tuesday on the back of the new project bagged by the company.
Jio Fiber plans pulls down PVR and Inox Jio Fiber plans pulls down PVR and Inox Amir Shaikh / Tuesday, August 13, 2019 / Article rating: 3.0 Reliance Industries' (RIL) AGM on Monday brought cheers to its shareholders and customers, but on the flip side, it was painful for stocks like PVR and Inox, which tanked nearly 10 per cent and 8 per cent, respectively.
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Tuesday, August 13, 2019 / Article rating: 5.0 Overall volumes in futures & options currently stand at 1,30,42,820 contracts with a turnover of Rs.8,68,187.66 crore.